News Articles

Julphar Reports First Six Months Earnings Ras Al Khaimah, United Arab Emirates -Wednesday, August 16th 2017 [ar]  

Julphar, the largest generic pharmaceutical manufacturer in Middle East and North Africa (MENA), announced sales revenue of AED 639 million in the first semester of the year 2017. The company posted a net profit of AED 64 million. Julphar’s Chairman, His Highness Sheikh Faisal Bin Saqr Al...

Gulf Inject partners with Zulekha Healthcare Group Dubai, United Arab Emirates. -Thursday, August 10th 2017 [ar]  

Gulf Inject, a Julphar company - the region’s leading pharmaceutical manufacturer, has announced it has signed a local distribution agreement with Zulekha Healthcare Group. The business milestone event was held at the Gulf Inject manufacturing facility located in the Jebel Ali Free Zone,...

Julphar Brings Dandasha to UAE Ras Al Khaimah, United Arab Emirates -Thursday, June 8th 2017 [ar]  

The Emirati pharmaceutical company Julphar Gulf Pharmaceutical Industries, one of the key players in the region, has launched a new drug – Dandasha – in the UAE market to treat erectile dysfunction (ED) in adult men. Marketed in tablets form, Dandasha (Tadalafil 20 mg) is an inhibitor of...

Julphar’s Board of Directors Meeting Held on May 18th, 2017 Ras Al Khaimah, United Arab Emirates -Thursday, May 25th 2017 [ar]  

During the meeting held on May 18th 2017, Julphar Gulf Pharmaceutical Industries’ Board of Directors released the company’s quarterly results and business achievements for the first three months of the year. The Board discussed the situation in Middle East and North Africa (MENA),...

AED 1.45 billion Julphar sales in 2016 Ras Al Khaimah, United Arab Emirates -Wednesday, April 19th 2017 [ar]  

Led by its Chairman His Highness Sheikh Faisal Bin Saqr Al Qasimi, Julphar’s General Assembly Meeting took place in the company’s headquarters of Ras Al Khaimah on April 16th. During the meeting, the General Assembly decided to distribute 16 per cent of profits in cash in addition to 3 per...

Julphar Announces Full Year 2016 Financial Results Ras Al Khaimah, United Arab Emirates -Sunday, April 9th 2017 [ar]

Julphar Gulf Pharmaceutical Industries, the largest generic pharmaceutical manufacturer in Middle East and North Africa (MENA), announced it has closed the year 2016 with sales of AED 1.45 billion. Despite the challenging and rapidly changing market environment, Julphar continued to perform...

Julphar’s Board of Directors names CFO Jerome CARLE as Acting General Manager Ras Al Khaimah, United Arab Emirates -Sunday, March 26th 2017 [ar]  

The Board of Directors of Julphar Gulf Pharmaceutical Industries – chaired by His Highness Sheikh Faisal Bin Saqr Al Qassimi – announced that it has appointed Julphar’s Chief Financial Officer Jerome Carle as Acting General Manager, which will be effective following the departure of...

Julphar Offers Refresher cGMP Training for 500 Employees Ras Al Khaimah, United Arab Emirates -Sunday, March 12th 2017 [ar]  

Julphar Gulf Pharmaceutical Industries conducted a periodic refresher training on “Current Good Manufacturing Practices (cGMP) and safety at workplace” for 500 employees working in the areas of packaging,during the month of February, 2017. The training sessions were conducted by...

Julphar Gives Positive Outlook for 2017 Ras Al Khaimah, United Arab Emirates -Sunday, February 12th 2017 [ar]

Julphar’s Board of Directors, chaired by His Highness Sheikh Faisal Bin Saqr Al Qasimi, met on January 26th to review the company’s last year performance and future expectations. The Board expressed its satisfaction and reported a positive outlook for 2017. Despite the difficult and...

Julphar CEO Leaves the Company after 8 Years of Service Ras Al Khaimah, United Arab Emirates -Sunday, January 29th 2017 [ar]

Upon expiration of his contract – which comes in Q2 2017 – Dr Ayman Sahli, Chief Executive Officer of Julphar, has decided not to renew. The Board respects his wishes and has accepted his decision. Processes are underway to select his successor. Commenting on Dr Ayman’s decision, His...

Julphar Appoints New CFO Ras Al Khaimah, United Arab Emirates -Monday, January 9th 2017 [ar]  

Julphar’s Board of Directors has announced the appointment of Jerome Carle who has joined the company as Chief Financial Officer, effective January 8th, 2017. In his new position, Jerome will be responsible for leading Julphar’s finance department and keeping accurate financial records....

Julphar launches a new antibiotic in UAE Ras Al Khaimah, United Arab Emirates -Monday, December 12th 2016 [ar]  

Julphar Gulf Pharmaceutical Industries launched the antibiotic Voxin during a launch event, which was held at the Raffles Hotel, Dubai on November 25th 2016. “Voxin (Levofloxacin) is a fluoroquinolone antibiotic that is indicated for the treatment of lower respiratory tract infections and...

Julphar launches the first app to study dyslipidemia in the region Ras Al Khaimah, United Arab Emirates -Monday, October 3rd 2016 [ar]  

Julphar Gulf Pharmaceutical Industries, the largest generic pharmaceutical company in Middle East and North Africa (MENA), has launched PULSE – the first research application in the region to study behaviors and attitudes in disease management, during a launch event that took place at the Park...

Results 1-13 of 13